GREM1 and cancer: To further clarify GREM1’s role in cancer prognosis, we performed a pan-cancer analysis in the TCGA cohort, showing that high GREM1 expression is strongly associated with poor prognosis across multiple cancer types, especially in tumors with high TMB and substantial immune cell infiltration (24, 25).